Delivery Order SPE2DB22D3016-SPE2DB25FAYK8

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,358.09 delivery order contract is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication. The contract has a performance period through May 14, 2025 and is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a $3,323.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ambien CR 6.25 mg tablets. It has a completion date of June 6, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ambien CR 6.25 mg tablets, with a ceiling value of $3,635.50 and a period of performance through May 19, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,082.73 firm fixed-price delivery order is for AMBIEN CR 6.25 MG TABLET 100S and has a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,256.86 firm-fixed-price delivery order is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,163,597 units of Ambien CR 6.25 mg tablets, with a firm fixed price of $3,303.66 and a period of performance through May 8, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order award to AmerisourceBergen Drug Corp under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for $1,519.56 to provide Ambien CR 6.25 mg tablets to support military treatment programs and facilities worldwide. The IDC has a ceiling value of up to $999,999,999 through December 2025 for a comprehensive range of medical commodities. This delivery order does not have a set-aside designation. AmerisourceBergen, as...
This federal contract award, valued at $1,202.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ambien CR 6.25 mg tablets and has an ultimate completion date of April 29, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,744.98 firm fixed-price delivery order is for the supply of AMBIEN CR 6.25 MG TABLET 100S, with a period of performance through November 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,939.15 firm fixed-price delivery order is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a sleep medication. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAYK8
    Delivery Order

This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply AMBIEN CR 6.25 MG TABLET 100S. The contract has a firm fixed price of $1,806.02 and a period of performance through June 6, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/4/25, 9:57 AM